Navigation Links
ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
Date:3/18/2009

for the new draft guidance expires on March 19, 2009. OGD has acknowledged the complexity of the issues involved, and specifically stated that the Agency will carefully consider all comments before responding to ViroPharma's Citizen Petition and finalizing BE recommendations for Vancocin.

"While we appreciate that the FDA has provided a limited level of public process, we continue to vehemently disagree with an approach that we believe places patient lives in the hands of an unproven method that is riddled with assumptions, and the result of a profoundly flawed process which could lead to sub-therapeutic versions of Vancocin," said Thomas Doyle, ViroPharma's vice president of strategic initiatives. "We reiterate our willingness to assist FDA in any way we can in the development of a rigorous method that will ensure the approval of safe and effective generic versions of Vancocin. We note in our comments that will we share the data from the ongoing study we are sponsoring at Temple University regarding the GI conditions to be found in patients with CDI, preliminary data from which indicate that CDI patients do not exhibit the healthy GI physiology asserted by OGD. We are also willing to provide FDA with unrestricted financial support for efforts aimed at developing a scientifically rigorous bioequivalence method for generic copies of Vancocin."

Some of the many points of concern over the draft BE Guidelines described in ViroPharma's submission include:

  • The December 2008 Draft Guidance method is not correlated with patient outcomes, as the law and good science require.
  • Documented examples repeatedly demonstrate OGD's poor judgment and bad faith in developing bioequivalence methods for Vancocin.
  • OGD has gone to great lengths to avoid any consideration of the actual environment in which Vancocin will be used - patients with infected GI tracts - t
    '/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
2. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
3. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
4. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
7. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
8. ViroPharma to Present at the Natixis Bleichroeder Conference
9. ViroPharma to Present at Three Upcoming Healthcare Conferences
10. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
11. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... BOULDER, Colo. , April 27, 2015 ... will report financial results for the third ... conference call to discuss those results on ... Executive Officer will lead the call.Date:Monday, May ... Code: 5249676 Webcast, including Replay and Conference ...
(Date:4/27/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today that it has received a close-out ... ("FDA") verifying that the Company has successfully implemented corrective ... received from the FDA in January 2013. ... by the FDA at CryoLife,s manufacturing facility and headquarters ...
(Date:4/27/2015)... NEW YORK , April 27, 2015   ... management solutions, will showcase advances in monitored care that ... the upcoming ATA 2015 Conference, May 2-5 ... Center. AMC Health will share information about ... monitored care to help transform and personalize healthcare delivery ...
Breaking Medicine Technology:CryoLife Announces Resolution of FDA Warning Letter 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4
... DIEGO, Oct. 13 RESMED INC. (NYSE: RMD ... will release its results for the first quarter of fiscal ... ResMed,s results will be issued after 1:00 p.m. Pacific Time ... to review its results, market trends, and future outlook. ...
... Care Continuum Alliance honored Kaiser Permanente,s ALL/PHASE initiative ... on Health" at The Forum 10 conference ... low-cost and generic medications and clinical interventions to reduce ... communities, including those served by safety net organizations. ...
Cached Medicine Technology:ResMed Announces Conference Call and Webcast to Discuss First Quarter 2011 Results 2Kaiser Permanente's ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health 2Kaiser Permanente's ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health 3
(Date:4/28/2015)... 28, 2015 According to Professor Donald ... (June 27, 2014), prescription drugs are the fourth ... is becoming increasingly aware of the limitations and dangers ... as chemotherapy drugs to treat cancer, Prozac for depression ... evolving to become increasingly resistant to current drugs and ...
(Date:4/28/2015)... Foundations Recovery Network (FRN), an innovative behavioral ... of its Memphis based residential treatment facility. The facility ... be known as The Oaks at LaPaloma, a name ... beautiful old Oak trees long regarded for their sheltering ... the commitment and dedication to helping people find freedom ...
(Date:4/27/2015)... 2015 Women may have a more ... to a new study published online in the journal ... injury (MTBI), is a common medical problem affecting cognitive ... , In most cases, patients who experience MTBI will ... percent of MTBI patients will continue to experience persistent ...
(Date:4/27/2015)... "Understanding Mental Disorders: Your Guide to the DSM-5®" ... Publishing, a division of the American Psychiatric Association. The ... Press Club in Washington, D.C.. The launch event will ... Paul Summergrad, MD. Guest speakers will include Former Congressman ... book; Paul Gionfriddo, President and CEO of Mental Health ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 On April 16, ... Get Rid of Stretch Marks ,” interviewed a UK ... . Stretch marks are a type of scar ... are caused by a breakdown of the elsastin and collagen ... (see: goo.gl/iRdmEe) , “Stretch mark removal with the Coolbeam ...
Breaking Medicine News(10 mins):Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 2Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 3Health News:Trivedi Science™ Announces the Beginning of Their Science Research to Create Highly Effective Pharmaceutical Drugs with Minimal Side Effects 4Health News:Foundations Recovery Network Rebrands LaPaloma Treatment Center as The Oaks at LaPaloma 2Health News:Women Show Persistent Memory Impairment after Concussion 2Health News:Women Show Persistent Memory Impairment after Concussion 3Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2Health News:Stretch Marks: The Latest Treatment Options for Stretch Mark Removal 2
... The following is a,statement of William V. Corr, ... and legislative leaders have broken Ohio,s,promise to protect its ... the state,s highly successful tobacco prevention program, run by ... price if this raid,is carried out. More kids will ...
... a,bipartisan compromise brokered by Foreign Affairs Committee Chairman ... to expand the,landmark U.S. effort to combat HIV/AIDS ... millions of lives., Despite efforts by some ... provides, the Tom Lantos and Henry J. Hyde ...
... 2, 2008 Christopher T. Olivia, M.D.,president and ... Health,System, today met with more than 60 regional ... of benefits-rich healthcare plans,now offered to businesses and ... Dr. Olivia and other executives with West Penn ...
... April 2, 2008 In celebration of,AARP,s 50th ... public high schools throughout the nation, AARP today,announced ... Awards. AARP has,donated more than $1 million nationally ... to connect generations and foster,greater civic engagement among ...
... between best and worst states, with Vermont on top and ... -- For American children, where they are born and raised ... staying healthy and living to adulthood, a new report finds. ... the States , from the Every Child Matters Education Fund, ...
... Live Auction At ADA,s ... Chrysler Jeep Superstores Will Help Children And Teens Attend ... ADA,s Camp Midicha, ... big boost thanks to the generous donation,of a two-year lease for a 2008 ...
Cached Medicine News:Health News:Gov. Strickland, Legislative Leaders Break Promise to Protect Ohio's Kids from Tobacco 2Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 2Health News:House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort 3Health News:New West Penn Allegheny CEO Meets With Insurance Brokers 2Health News:AARP Legacy Award Celebrates Seaford High School for Innovation in Education 2Health News:AARP Legacy Award Celebrates Seaford High School for Innovation in Education 3Health News:Report Finds Big Disparities in Well-Being of U.S. Kids 2Health News:Report Finds Big Disparities in Well-Being of U.S. Kids 3Health News:Report Finds Big Disparities in Well-Being of U.S. Kids 4Health News:Diabetes Research, Advocacy and Education Gets Big Boost with Donation of Two- Year Lease for 2008 Chrysler Sebring Convertible 2
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
... Type 14, 14A and 14C have been approved. ... to accommodate the variations in the size of ... tension rings are designed to stabilize the capsule ... large panel of U.S. ophthalmologists. For implatations ...
... is a device designed for permanent implantation ... removal surgery. It provides secondary capsular bag ... The CTR is a uniplanar, 270-degree, semi-circle ... absorbing polymethylmethacrylate (PMMA) with one manipulation eyelet ...
Stainless steel cartilage scissors....
Medicine Products: